September 10, 2008Novartis Kidney Cancer Treatment Is Granted Priority FDA Review - Wall Street Journal Novartis Kidney Cancer Treatment Is Granted Priority FDA Review - Wall Street Journal
ZURICH -- Novartis AG said Tuesday its experimental drug Afinitor has been granted priority review by the U.S. Food and Drug Administration for approval as treatment for advanced kidney cancer, paving the way for possible approval early next year Source: online.wsj.com # posted by Network @ 6:00 PM
 |
Subscribe to Posts [Atom]